Position in NBIX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$74,388,668
+$28,186,133 QoQ
Shares Held
441,371
+25.9% QoQ
Ownership
0.434%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#44
of 768 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026ACADIAN ASSET MANAGEMENT LLC holds $533,943,071 across 32 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (13.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
318,320 | $172,475,325 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
This page
|
441,371 | $74,388,668 | |
| 3 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
679,083 | $43,427,357 | |
| 4 | RDY |
Dr Reddys Laboratories Ltd
|
2,260,243 | $32,750,921 | |
| 5 | INDV |
Indivior Pharmaceuticals, Inc.
|
733,974 | $30,114,953 | |
| 6 | AMRX |
Amneal Pharmaceuticals, Inc.
|
1,650,255 | $28,565,914 | |
| 7 | BHC |
Bausch Health Companies Inc.
|
5,482,986 | $27,031,120 | |
| 8 | ZTS |
Zoetis Inc.
|
364,442 | $26,188,802 |
All Filings in NBIX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $74,388,668 | 441,371 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $46,202,535 | 350,710 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $35,337,511 | 249,154 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $5,540,798 | 39,470 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $405,727 | 3,228 | Shares | Defined | 2025-08-07 | |
| 2025-03-31 | $337,772 | 3,054 | Shares | Defined | 2025-05-21 | |
| 2024-12-31 | $364,591 | 2,671 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $2,188,258 | 18,992 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $573,257 | 4,164 | Shares | Defined | 2024-08-06 | |
| 2024-03-31 | $478,030 | 3,466 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $4,116,709 | 31,244 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $5,261,850 | 46,772 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $2,266,123 | 24,031 | Shares | Defined | 2023-08-07 | |
| 2023-03-31 | $10,897,345 | 107,660 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $6,372,004 | 53,349 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $3,515,126 | 33,096 | Shares | Defined | 2022-11-14 | |
| 2022-03-31 | $27,468 | 293 | Shares | Defined | 2022-05-12 | |
| 2021-06-30 | $150,554 | 1,547 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $447,155 | 4,598 | Shares | Defined | 2021-05-11 | |
| 2020-12-31 | $93,933 | 980 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $1,078,915 | 11,220 | Shares | Defined | 2020-11-09 | |
| 2020-06-30 | $965,630 | 7,915 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $97,628 | 1,128 | Shares | Defined | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||